| Primary |
| Schizophrenia |
20.7% |
| Psychotic Disorder |
15.9% |
| Product Used For Unknown Indication |
9.8% |
| Self Injurious Behaviour |
9.8% |
| Aggression |
7.3% |
| Agitation |
7.3% |
| Depression |
4.9% |
| Blood Pressure |
2.4% |
| Catatonia |
2.4% |
| Delirium |
2.4% |
| Hallucination |
2.4% |
| Restlessness |
2.4% |
| Schizophrenia, Disorganised Type |
2.4% |
| Schizophrenia, Paranoid Type |
2.4% |
| Acute Psychosis |
1.2% |
| Anaesthesia |
1.2% |
| Anxiety |
1.2% |
| Ballismus |
1.2% |
| Bipolar Disorder |
1.2% |
| Dementia |
1.2% |
|
| Pulmonary Embolism |
12.1% |
| Medication Error |
9.1% |
| Circumstance Or Information Capable Of Leading To Medication Error |
6.1% |
| Disease Recurrence |
6.1% |
| Drug Hypersensitivity |
6.1% |
| Dyskinesia |
6.1% |
| Electrocardiogram Qt Prolonged |
6.1% |
| Neuroleptic Malignant Syndrome |
6.1% |
| Pyrexia |
6.1% |
| Torsade De Pointes |
6.1% |
| Anaphylactic Shock |
3.0% |
| Anxiety |
3.0% |
| Back Pain |
3.0% |
| Blood Creatine Phosphokinase Increased |
3.0% |
| Blood Magnesium Decreased |
3.0% |
| Blood Potassium Decreased |
3.0% |
| Blood Pressure Decreased |
3.0% |
| Body Temperature Increased |
3.0% |
| Bradykinesia |
3.0% |
| Cardiac Arrest |
3.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.2% |
| Product Used For Unknown Indication |
18.2% |
| Pain |
12.1% |
| Anaesthesia |
7.1% |
| Dementia |
7.1% |
| Agitation |
6.1% |
| Schizophrenia |
6.1% |
| Psychotic Behaviour |
5.1% |
| Delirium Tremens |
3.0% |
| Depression |
3.0% |
| Anxiety |
2.0% |
| Blood Pressure |
2.0% |
| Epilepsy |
2.0% |
| General Anaesthesia |
2.0% |
| Abstains From Alcohol |
1.0% |
| Delirium |
1.0% |
| Dementia Alzheimer's Type |
1.0% |
| Hypertension |
1.0% |
| Restlessness |
1.0% |
| Sedation |
1.0% |
|
| Blood Creatine Phosphokinase Increased |
15.2% |
| Catatonia |
9.1% |
| Gaze Palsy |
6.1% |
| Maternal Exposure Before Pregnancy |
6.1% |
| Medication Error |
6.1% |
| Oliguria |
6.1% |
| Pierre Robin Syndrome |
6.1% |
| Snoring |
6.1% |
| Tachycardia |
6.1% |
| Blood Pressure Increased |
3.0% |
| Circumstance Or Information Capable Of Leading To Medication Error |
3.0% |
| Eye Pruritus |
3.0% |
| Gestational Diabetes |
3.0% |
| Haemorrhagic Anaemia |
3.0% |
| Hypercapnia |
3.0% |
| Maternal Exposure During Pregnancy |
3.0% |
| Neuroleptic Malignant Syndrome |
3.0% |
| Overdose |
3.0% |
| Respiratory Failure |
3.0% |
| Rhabdomyolysis |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
66.5% |
| Drug Use For Unknown Indication |
9.5% |
| Metastases To Bone |
4.7% |
| Mantle Cell Lymphoma |
2.1% |
| Prophylaxis |
2.0% |
| Osteoporosis |
1.8% |
| Pain |
1.6% |
| Breast Cancer |
1.3% |
| Nausea |
1.3% |
| Acute Myeloid Leukaemia |
1.0% |
| Dyspnoea |
1.0% |
| Hypertension |
1.0% |
| Agitation |
0.9% |
| Plasma Cell Myeloma |
0.9% |
| Sleep Disorder |
0.8% |
| Vomiting |
0.8% |
| Constipation |
0.7% |
| Pyrexia |
0.7% |
| Blood Pressure |
0.6% |
| Haemodialysis |
0.6% |
|
| White Blood Cell Count |
14.6% |
| Hypotension |
7.3% |
| Thrombocytopenia |
7.3% |
| Urosepsis |
7.3% |
| Vomiting |
7.3% |
| Dysphagia |
4.9% |
| Multi-organ Failure |
4.9% |
| Neoplasm Malignant |
4.9% |
| Sepsis |
4.9% |
| Suicide Attempt |
4.9% |
| Tachycardia |
4.9% |
| Unresponsive To Stimuli |
4.9% |
| Venoocclusive Liver Disease |
4.9% |
| Abdominal Distension |
2.4% |
| Acute Respiratory Distress Syndrome |
2.4% |
| Amnesia |
2.4% |
| Atrioventricular Block Complete |
2.4% |
| Bone Graft |
2.4% |
| Brachial Plexopathy |
2.4% |
| Cardiac Failure |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
97.8% |
| Analgesic Therapy |
2.2% |
|
| Agranulocytosis |
50.0% |
| Amnesia |
50.0% |
|
